Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zephyr AI
AddedFeb 15, 2024
UpdatedJun 18, 2026
Zephyr AI

Zephyr AI

Seed

Zephyr AI: Revolutionizing healthcare with innovative drug discovery and precision medicine tech.

HQ
Dallas, TX, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Zephyr AI, founded with the mission to revolutionize healthcare, focuses on innovative drug discovery and precision medicine. Leveraging an AI-enabled platform, Zephyr AI utilizes vast and diverse healthcare and biological data to uncover hidden insights, match patients to drugs, and accelerate the development of new medications. Their technology aims to deliver robust, real-world efficacy in clinical settings, ensuring that every discovery reaches its full potential in patient care.

Notable figures affiliated with Zephyr AI include experts in healthcare technology and precision medicine. The company has attracted significant investment from leading venture capital firms specializing in biotech and AI. Key achievements include the successful implementation of their platform in clinical environments and partnerships with major healthcare institutions. Zephyr AI's impact lies in its ability to make drug discovery more efficient and patient-centric, ultimately transforming the landscape of precision medicine.

Zephyr AI - Similar Companies

BioAI Health logo

BioAI Health

bioaihealth.com

Pathos AI logo

Pathos AI

pathos.com

Insitro logo

Insitro

insitro.com

TandemAI logo

TandemAI

tandemai.com

Ariz Precision Medicine logo

Ariz Precision Medicine

arizbio.com

Ambit.AI logo

Ambit.AI

ambit.ai

DeepCure logo

DeepCure

deepcure.ai

Precision Health AI logo

Precision Health AI

Terray Therapeutics logo

Terray Therapeutics

terraytx.com

Cipherome logo

Cipherome

cipherome.com

Zymeron logo

Zymeron

zymeron.com

Phronesis Artificial Intelligence logo

Phronesis Artificial Intelligence

phronesisai.com

Model Medicines logo

Model Medicines

modelmedicines.com

Verge Genomics logo

Verge Genomics

vergegenomics.com

Insilico Medicine logo

Insilico Medicine

insilico.com

Zephyr AI - Quick Facts

Who are Zephyr AI's competitors?

Companies similar to Zephyr AI include BioAI Health, Pathos AI, Insitro and TandemAI.

When was Zephyr AI founded?

Zephyr AI was founded in 2020.

Where is Zephyr AI's headquarters located?

Zephyr AI's headquarters is located in Dallas, TX, US.

When was Zephyr AI's last funding round?

Zephyr AI's most recent funding round was for $18.5M (USD) in March 2022.

How much has Zephyr AI raised to-date?

As of Mar 30, 2022, Zephyr AI has raised a total of $18.5M (USD).

How many employees does Zephyr AI have?

Zephyr AI has 47 employees as of Feb 5, 2024.

Zephyr AI - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
  • Precision Medicine
Tags
  • Biotech
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 16 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 620000Health Care and Social Assistance
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541510Computer Systems Design and Related Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
  • 541511Custom Computer Programming Services
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7371Computer Programming Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research